2025-12-12 sec-litreleases judgment 2663 KB 140 chars

SEC v. RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.; and DONAL R. SCHMIDT, JR., No. 3:23-cv-2081, Northern District of Texas (Dec. 12, 2025) — Judgment

raw: SEC v. RAPID THERAPEUTIC SCIENCE

SEC v. RAPID THERAPEUTIC SCIENCE, No. 3:23-cv-2081 (Dec. 12, 2025)

Caption
Securities and Exchange Commission v. Rapid Therapeutic Science Laboratories, Inc. and Donal R. Schmidt, Jr.
Source PDF JSON

Enriched metadata

Scheme
unregistered-securities (90%)
Court
Northern District of Texas
Case No.
3:23-cv-2081
Outcome
settled
Disgorgement
$686,090
Classified unregistered-securities(confidence 90%). EDGAR detection: forms Form D/S-1· recall 41% / precision 30%. detection rule →
Statutes
15 U.S.C. § 78j(b)15 U.S.C. § 77q(a)15 U.S.C. § 77e15 U.S.C. § 77h15 U.S.C. § 78m(a)28 U.S.C. § 196117 C.F.R. § 240.10b-5Section 10(b) of the Securities Exchange ActSection 17(a) of the Securities ActSection 5 of the Securities ActSection 8 of the Securities ActRule 10b-5
Parties
Securities and Exchange CommissionRAPID THERAPEUTIC SCIENCE LABORATORIES, INC.DONAL R. SCHMIDT, JR.
Keywords
ordered adjudgedadjudged decreedfurther orderedcommissionfinalordereddocument pagepage pageidfurthersecuritiesadjudgeddecreedrapid therapeutictherapeutic sciencesecurities exchange

Extracted insights

Entities 4
  • person Donal R. Schmidt, Jr.
  • person general appearance
  • company Rapid Therapeutic Science Laboratories, Inc.
  • agency Securities and Exchange Commission
Triples 8
  • Securities And Exchange Commission filed Complaint
  • Rapid Therapeutic Science Laboratories, Inc. entered general appearance
  • Rapid Therapeutic Science Laboratories, Inc. consented to the Court’s jurisdiction over Defendant and the subject matter of this action
  • Rapid Therapeutic Science Laboratories, Inc. consented to entry of this Final Judgment without admitting or denying the allegations of the Complaint
  • Rapid Therapeutic Science Laboratories, Inc. waived findings of fact and conclusions of law
  • Rapid Therapeutic Science Laboratories, Inc. waived any right to appeal from this Final Judgment
  • Court ordered Defendant is permanently restrained and enjoined from violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5
  • Court ordered Defendant is permanently restrained and enjoined from violating Section 17(a) of the Securities Act of 1933
PDF
SEC v. RAPID THERAPEUTIC SCIENCE · Source
Text layers
Extracted body text (140c) 
[OCR_UNRECOVERABLE method=recover reason=missing_pdf ts=2026-09-26T14:05:04.896Z]

Related documents (1)